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INTRODUCTION 
Idiopathic thrombocytopenic purpura (ITP) is the most 
common autoimmune blood disorder with different 
pathogenetic and clinical features in children and adults 
which determined through two mechanisms (produce 
antibodies against the platelets antigens by phagocytic 
cells specialty in the spleen and early destruction of 
platelets.1-2 
The prevalence of ITP in the United States of America 
were 50 cases, in Danish and UK 10-40 cases and in 
Kuwait more than 125 cases per one million people per 
year.3 
ABSTRACT 
 
Background: Idiopathic thrombocytopenic purpura (ITP) is the most common autoimmune blood disorder which 
leads to premature destruction of platelets by producing antibodies using phagocytic cells against antigens of platelets 
surface especially in the spleen. Recently, several studies have reported the high prevalence of H. pylori infection in 
adult patients with chronic ITP, but the studies performed in this area have been very limited in children. The purpose 
of this study is to investigate the prevalence of Helicobacter pylori infection in children with chronic ITP.  
Methods: In this case- control study, the case sample includes 30 children in the age range of 2-16 years with chronic 
ITP and control samples includes 90 children in the age range of 2-16 years who are healthy in terms of ITP disease. 
A questionnaire and a stool sample is prepared for each sample. These samples are examined by the method of 
ELIZA kit for the presence or absence of antigen H. Pylori. Data analyzed by statistical methods in SPSS.19.  
Results: Of the total 30 children with chronic ITP who has referred to the haematology ward of the hospital, H.pylori 
+ 16.7%, we had H.pylori + 20% from a total of 90 controls (P=0.68). The average age of the case and control groups 
were 6.9±2.8 and 6.9±3 years, respectively; there is no a direct relationship between helicobacter pylori infection and 
sex, drinking water, but there is a statistically significant difference between platelet levels and the prevalence of H 
Pylori in the case group (p<0.05); however, this difference is not significant in the control group. 
Conclusions: According to a conducted study, Helicobacter pylori infection is not considered as a factor risk in the 
development of chronic thrombocytopenic purpura in children. So, it is recommended that further studies to be done 
in different ethnic groups in the world with more samples, especially in the age range of children, so that the role of 
Helicobacter pylori in the pathogenesis of chronic autoimmune thrombocytopenic purpura can be determined 
accurately.  
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Usually the disease occurs in children as 
thrombocytopenia, purpura, petechial rash, spontaneous 
bruising and mucosal bleeding (usually in the form of 
epistaxis) and divided clinically in two sections acute and 
chronic.4 
In the acute form of the disease that is more common (70-
80%), platelet count during the first 4 to 8 weeks and 
maximum up to 6 months returns to the normal level. The 
chronic form of disease refers to cases in which the 
platelet count between 6 and 12 months remain in less 
than 150 while the other causes of Thrombocytopenia not 
raised (including drugs, collagen scholar diseases and 
Hepatitis C, HIV) and hypoplasia of megakaryocytes 
level not seen in bone marrow aspiration.5-6 
50-65% of patients with ITP have history of viral 
infection 1-4 weeks before and most of children have no 
symptoms in time of ITP incidence. Some vaccines such 
as triple vaccine and hepatitis B can cause disease 
incidence and in the spring, the acute type of ITP is more 
common. The relationship between H. pylori infection 
and ITP has been investigated since 1998 by an Italian 
group reported increase of the platelet count in ITP 
patients. The effect of H. pylori on the pathogenesis of 
immune destruction of platelets, is not yet clear. 
However, it was reported that treatment and extirpation 
infection in the children can increase the number of 
platelets which should be considered.7 
H. pylori infection is usually acquired in childhood and 
remain for many years. The prevalence of H. pylori in 
childhood 10-80% and its highest prevalence were seen 
in developing countries. 80% of people infected with the 
bacterium are asymptomatic and in most children the 
infection didn’t leads to clear clinical disease. Only 15% 
of infected children have clinical signs that this is 
affected by factors such as host, environment and 
bacteria.8 The real infection rate among population in 
developing countries is more common and by increment 
age, poor economic and social conditions its prevalence 
rise.9 
The prevalence of H. pylori infection in children with ITP 
varies widely among world’s population. Generally, 
results of studies conducted on the ITP, showed that the 
prevalence of H. pylori infection in countries with high 
prevalence of infectious and autoimmune disease are 
more. Also, patients with ITP often are older than other 
patients. Given that H. pylori infection mainly occurs in 
childhood and could underline the prevalence of gastric 
cancer, peptic ulcer disease, ITP chronic and iron 
deficiency anemia, this study aimed to investigate the 
prevalence of H. pylori infection in children 2-16 years 
with chronic ITP.10  
METHODS 
In this case control study, the case group included 30 
children 2-6 years referred to Bu-Ali hospital that their 
ITP previously approved by specialist and more that 6 
months duration and the control group consisted of 90 
children 2-16 years of healthy patient. Two case and 
control groups were matched in term of age, gender, and 
residence place, family history of blood and digestive 
diseases and nutritional habits.  
After obtaining consent from parents for each of the 
samples a questionnaire was completed and a stool 
sample was taken of them. Children with platelet count 
less than 100*109 per liter and without thrombocytopenia 
cause were studied. Children with a history of proton 
pump inhibitors, H2 blockers, and antibiotic uses within 4 
weeks ago, liver disease, poor general health and artificial 
heart valves were excluded from study. After getting the 
stools, samples were studied by kite ELIZA (Enzyme- 
Linked Immunosorbent Assey) for the presence of 
antigen H. pylori. Collected data were analyzed using 
descriptive and analytical statistical methods in SPSS.16.  
RESULTS 
Of the 30 ITP cases, 16 children (53.3%) were boy and 
14 children (46.7%) were girl. In the control group 46 
child (51.1%) were girl and 44 children (48.9%) were 
boy. The average age of children in case group was 
6.9±2.8 age and in control group was 6.9±3 and the 
difference was not significant between the two groups. 30 
children in the case group 5 children (16.7%) had H. 
pylori (20% girl and 80% boy) and of the 90 children in 
control group, 18 case (20%) had H.pylori (55.6% girl 
and 44.4% boy) and there was no difference between two 
groups (Table 1). 
Table 1: Rate of H. pylori in two groups. 
p-value 
Control Case Groups 
Result of 
H.pylori test 
% n % n 
0.68 
20 18 16.7 5 + 
80 72 83.3 25 - 
100 90 100 30 Total 
Of positive cases with H. pylori in the study group, 9 
people (30.3%) and in control group, 10 people (11.5%) 
had positive history of peptic ulcer in the family. The 
prevalence of H. pylori in control group is the same in 
every age group but the prevalence of H. pylori in case 
group in the age group 7 years and more was 17.6% of 
the age group of less than 7 years was 15.4% but the 
difference was not signification.  
The patients with H. pylori in case group had platelet 
count less than 15000 and in the control group 16.7% had 
a platelet count less than 25000. There was a statistically 
significant difference between platelet levels and 
frequency of H. pylori in case group but there was no 
significant in the control group.  
Vafaie M et al. Int J Adv Med. 2017 Oct;4(5):1207-1211 
                                               International Journal of Advances in Medicine | September-October 2017 | Vol 4 | Issue 5    Page 1209 
There was no significant correlation between household 
economic status and H. pylori infection in both groups. 
71.7 % of the case group and 55% of the control group 
had taken from municipal water. In case group, 4 children 
(80%) with H. pylori and in the control group, 13 
children (72.2%) with H. pylori used municipal water. It 
can be said that the higher prevalence of H. pylori was 
found in the stool of people had used the municipal and 
spring water but there was no significant difference 
between two groups.  
DISCUSSION 
Till now many studies had been studied the possible role 
of infections (direct or indirect) in the occurrence of 
autoimmune diseases which can be pointed to the H. 
pylori microbe. Till now, many causes including viruses, 
vaccination, involvement of genetic factors and immune 
deficiency as the initiator production of auto antibodies in 
patients with ITP have been raised but in most cases the 
cause of the disease remains unknown. Firstly, Gasbarrini 
and colleagues considered H. pylori as a possible factor 
in occurrence of ITP. Although the mechanism by which 
H. pylori can be induced thrombocytopenia is still 
unknown.7 
Several studies have been done on the prevalence of H. 
pylori in patients with chronic ITP especially in adults 
but because of unknown the exact rate of H. pylori in 
patients and also doing most of them in adults, doing 
other studies in this topic is necessary.8-10 According to 
the study, infection with H. pylori infection in 30 children 
with a chronic ITP was 19.7% and in 90 healthy children 
with chronic ITP was 20% which wasn’t statistically 
significant. In previous conducted studies, the rate of H. 
pylori in patients with chronic ITP was from 5.3% to 
80%. In Company and Rezaei studies, H. pylori were 
seen in 8 persons of 40 children with ITP and 5 people of 
23 children in the control group (17.4%) that the 
difference was no statistically significant between two 
groups and in line with our study result. In the Hamidieh 
and et al study, the mean age of patients was 3.2±8.9 
years. Of all patients, 17 (54/9%) were female and 14 
(45.1%) were male. The mean platelet count was 
34.3±51.4 *109 (range from 5 *109 liters to 125 *109). 
The average duration of disease in the patients studied 
was 20.2 * 27.7 (ranging from 7 to 96 months). Of 
patients only 4 children (21.9%) infected with microbe H. 
pylori. There was no significant correlation between 
gender and positive H. pylori antigen in two groups. In 
Azarm and et al study, significant difference between 
infected and non-infected patients mean age and gender 
distribution. The mean of platelet count in patients 
infected and non-infected in the baseline was 3.5±3.7 * 
10 9 liters and 4.6±3.3 * 10 9 liters respectively and 
despite greater rate of chronic ITP disease in infected 
people, there wasn’t relation between H. pylori infection 
and chronic ITP occurrence.11 In Rajantie and et al study, 
there was statistically significant difference between 
platelet levels and frequency of H. pylori in case group 
(p=0.001) but not in control group. Also, in Company 
study platelet count in patients with chronic ITP 
associated with H. pylori significantly lower than patients 
with chronic ITP but without the H. pylori infection (p 
<0.05) which was in line with our study results.12  
In Vakili et al, study there was no statistically significant 
difference between infected and non-infected patients in 
terms of age, platelet count and duration of illness. Also, 
this study showed that the prevalence of H. pylori 
infection in children with chronic ITP is lower than 
adults. So, it can be concluded that H. pylori has not role 
in the occurrence of chronic ITP but in the kids deal to 
reducing platelets.9  
In this study, the relationship between economic level 
and the test result was not significant which contradiction 
with Rahimian and et al study results but in line with 
Ghanei study.9,8 
In the case of drinking water, the higher prevalence of H. 
pylori + in the stool of patients the urban water and 
spring water used in boiled water but a significant 
relationship between drinking water and infection in any 
of the cases group (p=0.88) and control group (p=0.19) 
was not observed is match with Rajantie study but not in 
line with Ghanei study.8,12  
In compare, the results of this study with studies 
conducted in three countries Taiwan, Finland, Japan it  
Was observed that the rate of H. pylori was 0%, 40.9% 
and 20%, respectively.13-15 
Compare these three study together and also compare 
their results with current study because of difference in 
the prevalence of H. pylori infection in these countries 
and using different research methods, was different. It is 
essential to note that in our country due to indiscriminate 
use of antibiotics in children, self-elimination of H. pylori 
can reduce the prevalence of these bacteria. In most 
previous studies the prevalence of H. pylori was higher 
than our study considering the fact that most of these 
studies have been conducted in adult age group and 
infection with Helicobacter pylori increase with age and 
infection in adults is chronic and does not improve 
without any specific treatment.16-18 
While in children, self-elimination (because of excessive 
use of antibiotics in children) can occur, compare 
frequency of H. pylori in patients with chronic ITP in two 
age groups (children and adults) is not correct. 
Accordingly compare of this study with other studies in 
Iran in adult age group was impossible.19,21 
By comparing several studies conducted in adults with 
limited studies that have been conducted on children, 
were resulted that the prevalence of H. pylori in children 
with chronic ITP not as much as adults. Although H. 
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pylori in adults may be one of the causes of chronic ITP 
but does not seem to be similar in children.22-26 
CONCLUSION 
The results showed that the prevalence of H. pylori 
infection in children with chronic ITP in compare with 
normal children was similar but platelet count in patients 
with chronic ITP along with H. pylori infection was 
significantly lower than patients with chronic ITP without 
H. pylori infection. It can be said that H. pylori infection 
does not lead to chronic ITP but in the children, deal to 
decline in platelets. So, doing future studies in different 
ethnic groups in the world with greater samples 
especially in children to exactly identification of H. 
pylori role in the pathogenesis of chronic ITP is 
recommended. 
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